Clover Health adds Senator Torricelli and Dr. Miller to board
The new directors fill vacancies on the Audit and Clinical Committees, bringing expertise in public policy and Medicare Advantage.
See the latest news and media coverage for Clover. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medicare Advantage plan provider
cloverhealth.comLast updated
In short: Clover posted strong Q2 2026 results: $28M GAAP net income, 48% membership growth, and a court-ordered star rating boost.
The new directors fill vacancies on the Audit and Clinical Committees, bringing expertise in public policy and Medicare Advantage.
The company improved full-year 2026 guidance across all metrics and expects continued growth in 2027 supported by strong cohort development and a 4.5 Star payment year.
The company also achieved market-leading MA membership growth and expects to meet or exceed full-year outlook.
Management will host a webcast at 5 p.m. ET on May 6 to discuss performance.
Clover Health Investments recently outlined its 2027 Medicare Advantage portfolio, highlighting $0-premium PPO options, low specialist copays, broad provider choice, and Clover Assistant-powered clinical decision...
Shares of Clover Health Investments rose after the company said its 2027 PPO Medicare Advantage plans were rated five stars by the Centers for Medicare...
Clover Health Investments (NASDAQ:CLOV) grew its share price by 8.53 percent on Thursday to finish a...
What Happened? A number of stocks fell in the morning session after bipartisan lawmakers introduced the Protecting Approved ...
Track Clover and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Clover and other trending companies.